CLINICAL_TRIALS
research
· 2025-06-05
Clinical Trial Update: LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients [NA]
Summary
Clinical trial update for LEADERS FREE IV comparing BioFreedom Ultra to BioFreedom in high-bleeding-risk coronary artery disease patients; recruitment is ongoin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosensors Europe SA | Conditions: Coronary Artery Disease, Chronic Stable Angina | NA | Status: RECRUITING